- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 3 residues within 4Å:- Chain A: H.122, D.123
- Ligands: ZN.1
6 PLIP interactions:1 interactions with chain A, 5 Ligand-Water interactions- Metal complexes: A:D.123, H2O.1, H2O.1, H2O.1, H2O.1, H2O.1
MG.5: 2 residues within 4Å:- Chain B: D.123
- Ligands: ZN.4
6 PLIP interactions:1 interactions with chain B, 5 Ligand-Water interactions- Metal complexes: B:D.123, H2O.4, H2O.4, H2O.5, H2O.5, H2O.5
MG.8: 2 residues within 4Å:- Chain C: D.123
- Ligands: ZN.7
6 PLIP interactions:1 interactions with chain C, 5 Ligand-Water interactions- Metal complexes: C:D.123, H2O.8, H2O.8, H2O.8, H2O.8, H2O.8
MG.11: 4 residues within 4Å:- Chain D: H.122, D.123, H.155
- Ligands: ZN.10
5 PLIP interactions:1 interactions with chain D, 4 Ligand-Water interactions- Metal complexes: D:D.123, H2O.10, H2O.11, H2O.11, H2O.11
- 4 x M98: (S)-3-(2-(3-CYCLOPROPOXY-4-(DIFLUOROMETHOXY)PHENYL)-2-(5-(1,1,1,3,3,3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL)THIAZOL-2-YL)ETHY L)PYRIDINE 1-OXIDE(Non-covalent)
M98.3: 14 residues within 4Å:- Chain A: Y.81, T.193, M.195, D.240, N.243, P.244, Y.251, W.254, T.255, I.258, M.279, Q.291, F.294, I.298
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.294
- Hydrogen bonds: A:Q.291
- pi-Stacking: A:F.294
M98.6: 16 residues within 4Å:- Chain B: Y.81, T.193, M.195, D.240, N.243, P.244, Y.251, W.254, T.255, I.258, F.262, M.279, S.290, Q.291, F.294, I.298
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:F.294
- Hydrogen bonds: B:Q.291
- pi-Stacking: B:F.294
M98.9: 16 residues within 4Å:- Chain C: Y.81, T.193, M.195, D.240, L.241, N.243, P.244, Y.251, W.254, T.255, I.258, F.262, M.279, Q.291, F.294, I.298
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:F.294
- Hydrogen bonds: C:Q.291
- pi-Stacking: C:F.294
M98.12: 16 residues within 4Å:- Chain D: Y.81, T.193, M.195, D.240, L.241, N.243, P.244, Y.251, W.254, T.255, I.258, F.262, M.279, Q.291, F.294, I.298
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:L.241, D:F.294
- Hydrogen bonds: D:Q.291
- pi-Stacking: D:F.294
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huai, Q. et al., Enantiomer Discrimination Illustrated by the High Resolution Crystal Structures of Type 4 Phosphodiesterase. J.Med.Chem. (2006)
- Release Date
- 2006-03-28
- Peptides
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x M98: (S)-3-(2-(3-CYCLOPROPOXY-4-(DIFLUOROMETHOXY)PHENYL)-2-(5-(1,1,1,3,3,3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL)THIAZOL-2-YL)ETHY L)PYRIDINE 1-OXIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huai, Q. et al., Enantiomer Discrimination Illustrated by the High Resolution Crystal Structures of Type 4 Phosphodiesterase. J.Med.Chem. (2006)
- Release Date
- 2006-03-28
- Peptides
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D